CD44 and cancer: Consistent with previous reports that EMT promotes stemness [3–5], the expression of a well-known cancer stem cell marker CD44 [19] decreased upon Ovol2-induced transition to E and increased upon Zeb1/Snail-induced transition to M (Fig 3D).